Biocatalysts from Biosynthetic Pathways: Enabling Stereoselective, Enzymatic Cycloether Formation on a Gram Scale
dc.contributor.author | Hollmann, Tim | |
dc.contributor.author | Berkhan, Gesche | |
dc.contributor.author | Wagner, Lisa | |
dc.contributor.author | Sung, Kwang Hoon | |
dc.contributor.author | Kolb, Simon | |
dc.contributor.author | Geise, Hendrik | |
dc.contributor.author | Hahn, Frank | |
dc.date.accessioned | 2020-06-05T12:52:06Z | |
dc.date.available | 2020-06-05T12:52:06Z | |
dc.date.issued | 2020-03-30 | |
dc.identifier.issn | 2155-5435 | |
dc.identifier.doi | 10.1021/acscatal.9b05071 | |
dc.identifier.uri | http://hdl.handle.net/10033/622283 | |
dc.description.abstract | Biosynthetic pathways of natural products contain many enzymes that contribute to the rapid assembly of molecular complexity. Enzymes that form complex structural elements with multiple stereocenters, like chiral saturated oxygen heterocycles (CSOH), are of particular interest for a synthetic application, as their use promises to significantly simplify access to these elements. Here, the biocatalytic characterization of AmbDH3, an enzyme that catalyzes intramolecular oxa-Michael addition (IMOMA) is reported. This reaction essentially gives access to various types of CSOH with adjacent stereocenters, but it is not yet part of the repertoire of preparative biocatalysis. An in-depth study on the synthetic utility of AmbDH3 was performed, which made extensive use of complex synthetic precursor surrogates. The enzyme exhibited stability and broad substrate tolerance in in vitro experiments, which was in agreement with the results of molecular modeling. Its selectivity profile enabled kinetic resolution of chiral tetrahydropyrans (THPs) under control of up to four stereocenters. A systematic optimization of the reaction conditions enabled gram-scale conversions yielding preparative amounts of chiral THP. The synthetic utility of AmbDH3 was finally demonstrated by its successful application in the key step of a chemoenzymatic total synthesis to the THP-containing phenylheptanoid (−)-centrolobine. These results highlight the synthetic potential of AmbDH3 and related IMOMA cyclases as a biocatalytic alternative that further develops the available chemical-synthetic IMOMA methodology. | en_US |
dc.description.sponsorship | FP7 People: Marie-Curie Actions | en_US |
dc.language.iso | en | en_US |
dc.publisher | American Chemical Society (ACS) | en_US |
dc.rights | Attribution-NonCommercial-ShareAlike 4.0 International | * |
dc.rights.uri | http://pubs.acs.org/page/policy/authorchoice_termsofuse.html | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | * |
dc.title | Biocatalysts from Biosynthetic Pathways: Enabling Stereoselective, Enzymatic Cycloether Formation on a Gram Scale | en_US |
dc.type | Article | en_US |
dc.identifier.eissn | 2155-5435 | |
dc.contributor.department | HZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany. | en_US |
dc.identifier.journal | ACS Catalysis | en_US |
dc.identifier.pii | 10.1021/acscatal.9b05071 | |
dc.source.volume | 10 | |
dc.source.issue | 9 | |
dc.source.beginpage | 4973 | |
dc.source.endpage | 4982 | |
refterms.dateFOA | 2020-06-05T12:52:08Z | |
dc.source.journaltitle | ACS Catalysis |